Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Business Group Launches Anti-Reform Ad Campaign

By Drug Discovery Trends Editor | March 10, 2010

WASHINGTON (AP) – Major business groups announced a multimillion-dollar ad campaign to stop President Barack Obama’s health care overhaul as it approaches a make-or-break vote in the House.

The ad buy, costing between $4 million and $10 million, will start Wednesday on national cable TV outlets. Later in the week, the campaign shifts to 17 states home to moderate and conservative Democrats. Their votes are critical to Obama’s endgame for passing legislation to expand coverage and revamp the health insurance market.

The timing of the ads comes as Obama is building up momentum in his final health care drive. But congressional Democratic leaders are still short of the votes to pass the bill, and they’re courting many of the same lawmakers targeted by the business groups.

Health insurance companies, excoriated by Obama over a recent spate of double-digit premium hikes, are helping to pay for the ads, said Bruce Josten, a top lobbyist for the U.S. Chamber of Commerce, coordinating the campaign.

“Health care costs will go even higher under this bill, making things even more difficult for business,” said Josten. “We are trying to tell Congress to stop with this bill and start over, and get it moving in a direction that makes it more affordable.”

In addition to the Chamber of Commerce, other groups in the coalition include the National Association of Manufacturers, the National Retail Federation, and groups representing the construction and food service industries. The business groups refused to release a list of the lawmakers they are targeting.

Jeri Kubicki, an employee benefits expert with the manufacturing group, said employers are putting off hiring new workers because of concerns that the bill’s passage would raise their costs. “There is too much uncertainty,” she said.

The script for the ad says, “Health care costs will go even higher, making a bad economy worse.” It urges viewers to tell their lawmakers: “Stop this health care bill we can’t afford to pay.”

Separately, the health insurance industry lobby America’s Health Insurance Plans launched a $1 million-plus ad campaign Tuesday on national cable TV to push back against Obama’s recent criticism of insurers.

“What’s inside the health care cost pie? Some in Washington say it’s all health insurance,” the ad says. “But health insurance is one of the smallest slices. … If Washington wants to make health care more affordable they need to look at the whole health care pie not just a slice.”

Obama’s plan would not require companies to provide coverage to their workers, but it would slap a hefty fee on firms whose workers end up getting taxpayer-subsidized policies through a new health insurance marketplace. Companies with 50 or fewer workers would be exempt. Small businesses with up to 25 workers would be eligible for federal assistance to provide coverage.

Josten said the new requirements and penalties add up to a bad deal for business, and he predicted that fees on insurance companies, drug makers and other health industry players would be passed on to employers who provide coverage for most American workers and their families.

Date: March 9, 2010
Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
How stereo-correct data can de-risk AI-driven drug discovery
eConsent as the digital foundation for modern clinical trials 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE